DocSym
β
Searchsearch
Search
(P61.0) Transient neonatal thrombocytopenia
More details coming soon
325 367 in individuals diagnosis transient neonatal thrombocytopenia confirmed
3 002 deaths with diagnosis transient neonatal thrombocytopenia
1% mortality rate associated with the disease transient neonatal thrombocytopenia
Diagnosis transient neonatal thrombocytopenia is diagnosed Men are 12.21% more likely than Women
182 547
Men receive the diagnosis transient neonatal thrombocytopenia
1 628 (0.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
142 820
Women receive the diagnosis transient neonatal thrombocytopenia
1 374 (1.0 %)Died from this diagnosis.
Risk Group for the Disease transient neonatal thrombocytopenia - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 5-29, 35-49, 55-95+
In Women diagnosis is most often set at age 0-5, 30-34, 50-54
Disease Features transient neonatal thrombocytopenia
Absence or low individual and public risk
Transient neonatal thrombocytopenia - what does this mean
Transient neonatal thrombocytopenia is a condition in which a newborn baby has a lower than normal number of platelets in their blood. this is usually caused by the baby's immune system attacking and destroying its own platelets, which can lead to bleeding and bruising.
What happens during the disease - transient neonatal thrombocytopenia
Transient neonatal thrombocytopenia is a disorder of platelet production caused by an immune reaction in the mother against fetal platelets. during delivery, the mother's antibodies cross the placenta and attack the baby's platelets, leading to a decrease in the number of platelets in the baby's blood. this can cause bleeding, bruising, and other problems.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count
- Bone marrow aspiration and biopsy
- Umbilical cord blood analysis
- Maternal blood testing
- Flow cytometry analysis
- Molecular genetic testing
- Chromosome analysis
- Fetal ultrasound
Treatment and Medical Assistance
Main Goal: To improve the platelet count and prevent bleeding in the baby
- Administer intravenous immunoglobulin (IVIG) to baby
- Administer steroids to baby
- Monitor platelet count regularly
- Provide supportive care to baby
- Monitor for signs of bleeding
- Monitor for any signs of infection
- Provide nutritional support to baby
- Monitor for any signs of anemia
- Administer platelet transfusions if necessary
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Transient neonatal thrombocytopenia - Prevention
Transient neonatal thrombocytopenia can be prevented by avoiding preterm delivery, ensuring proper prenatal care, and avoiding maternal infections during pregnancy. additionally, mothers should be tested for platelet antibodies as early as possible in the pregnancy to identify any potential risks.